ERBB2 and breast carcinoma: Thus, these analyses uncovered the possible association of the CI functionality—the NAD+‐regenerating capability accompanied by electron transfer by NDUFS1, NDUFS7, and NDUFS8—with cancer progression in patients with HR(+)/HER2(−) breast cancer.